The consumer advocacy group Public Citizen has filed petition yesterday asking the U.S. Food and Drug Administration the take Novo Nordisk’s diabetes drug Victoza, alleging the drug poses a risk to the public, according to a Dow Jones Newswire report.
Read the full report in Becker’s Hospital Review on Novo Nordisk’s diabetes drug Victoza.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
